Safety and Efficacy of RVU120 for Treatment of Relapsed/Refractory AML

PHASE2Active, not recruitingINTERVENTIONAL
Enrollment

94

Participants

Timeline

Start Date

January 23, 2024

Primary Completion Date

February 28, 2026

Study Completion Date

September 30, 2026

Conditions
Acute Myeloid Leukemia (AML)High-risk Myelodysplastic Syndrome
Interventions
DRUG

RVU120

RVU120 is a potent, selective inhibitor of CDK8 and its paralog CDK19

Trial Locations (41)

10126

Azienda Ospedaliera Universitaria Citta Della Salute E Della Scienza Di Torino, Turin

20089

Humanitas Mirasole S.p.A., Rozzano

20162

ASST Grande Ospedale Metropolitano Niguarda, Milan

25123

Azienda Socio Sanitaria Territoriale Degli Spedali Civili Di Brescia, Brescia

40138

Univerisity of Bologna Policlinico Sant'Orsola, Bologna

47014

Istituto Romagnolo Per Lo Studio Dei Tumori Dino Amadori IRST S.r.l., Meldola

50134

Careggi University Hospital, Florence

56126

Azienda Ospedaliero Universitaria Pisana, Pisa

60126

Azienda Ospedaliero Universitaria Delle Marche, Ancona

73100

Ospedale Vito Fazzi Lecce, Lecce

Unknown

Centre Hospitalier Universitaire Grenoble Alpes, La Tronche

Centre Hospitalier Le Mans, Le Mans

Centre Hospitalier Universitaire de Lille (CHU Lille), Lille

Institut Paoli Calmettes (IPC), Marseille

Centre Hospitalier Universitaire (CHU) de Nice - Hopital L'Archet I, Nice

Centre Hospitalier Universitaire de Nimes (CHU) - Institut de Cancerologie du Gard, Nîmes

Publique-Hopitaux de Paris (AP-HP) - Hopital Saint-Louis, Paris

UNICANCER - Centre Henri-Becquerel, Rouen

Hospital de la Santa Creu i de Sant Pau, Barcelona

Hospital del Mar, Barcelona

Institut Catala d'Oncologia Hospitalet, Barcelona

Complejo Hospitalario De Caceres - Hospital General San Pedro De Alcantara, Cáceres

Hospital Universitario La Paz (HULP), Madrid

MD Anderson Cancer Center Madrid, Madrid

Hospital Regional Universitario de Málaga, Málaga

Clinica Universidad de Navarra, Pamplona

Virgen del Rocío University Hospital, Seville

Hospital Universitario La Fe, Valencia

00133

Azienda Ospedaliera Policlinico Universitario Tor Vergata, Roma

02-172

MTZ Clinical Research, Warsaw

21-500

Wojewodzki Szpital Specjalistyczny w Bialej Podlaskiej, Biała Podlaska

80-214

Uniwersyteckie Centrum Kliniczne, Gdansk

44-102

Narodowy Instytut Onkologii Im. Marii Sklodowskiej-Curie Panstwowy Instytut Badawczy, Gliwice

40-519

Pratia Hematologia Sp. z o.o., Katowice

16-400

Szpital Wojewodzki Im. Dr. Ludwika Rydygiera w Suwalkach, Suwałki

87-100

MICS Centrum Medyczne Toruń, Torun

02-776

Instytut Hematologii I Transfuzjologii, Warsaw

04-141

Wojskowy Instytut Medyczny Panstwowy Instytut Badawczy, Warsaw

58-309

Specjalistyczny Szpital Im. Dra Alfreda Sokolowskiego, Wałbrzych

53-439

Dolnoslaskie Centrum Onkologii Pulmonologii i Hematologii, Wroclaw

65-046

Szpital Uniwersytecki Imienia Karola Marcinkowskiego w Zielonej Gorze Sp. z o. o., Zielona Góra

All Listed Sponsors
lead

Ryvu Therapeutics SA

INDUSTRY

NCT06268574 - Safety and Efficacy of RVU120 for Treatment of Relapsed/Refractory AML | Biotech Hunter | Biotech Hunter